0001062993-23-010807.txt : 20230511
0001062993-23-010807.hdr.sgml : 20230511
20230511162931
ACCESSION NUMBER: 0001062993-23-010807
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230509
FILED AS OF DATE: 20230511
DATE AS OF CHANGE: 20230511
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hamilton Thomas Edward
CENTRAL INDEX KEY: 0001769848
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36510
FILM NUMBER: 23911498
MAIL ADDRESS:
STREET 1: 211 STUYVESANT AVE
CITY: RYE
STATE: NY
ZIP: 10580
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Larimar Therapeutics, Inc.
CENTRAL INDEX KEY: 0001374690
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 203857670
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: THREE BALA PLAZA EAST. SUITE 506
CITY: BALA CYNWYD
STATE: PA
ZIP: 19004
BUSINESS PHONE: 844-511-9056
MAIL ADDRESS:
STREET 1: THREE BALA PLAZA EAST. SUITE 506
CITY: BALA CYNWYD
STATE: PA
ZIP: 19004
FORMER COMPANY:
FORMER CONFORMED NAME: ZAFGEN, INC.
DATE OF NAME CHANGE: 20100301
FORMER COMPANY:
FORMER CONFORMED NAME: ZAFGEN INC
DATE OF NAME CHANGE: 20060906
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0407
4
2023-05-09
0001374690
Larimar Therapeutics, Inc.
LRMR
0001769848
Hamilton Thomas Edward
C/O LARIMAR THERAPEUTICS, INC.
THREE BALA PLAZA EAST, SUITE 506
BALA CYNWYD
PA
19004
1
0
0
0
0
Stock Option (Right to Buy)
5.09
2023-05-09
4
A
0
8300
0
A
2033-05-09
Common Stock
8300
8300
D
The options vest on the earlier of (a) May 9, 2024 or (b) the date of the Company's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service on the Board of Directors of the Company.
/s/ Jennifer Johansson, Attorney-in-fact
2023-05-11